Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Algos and NIDA enter into collaboration for heroin addiction treatment

Aug. 7, 1997

Nicotine Inhaler launched in The Netherlands

July 24, 1997

Novartis prepares orally active iron chelators

July 23, 1997

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

DynaGen licenses smoking cessation technology

June 6, 1997

FDA clears Glaxo Wellcome's aid to smoking cessation

May 16, 1997

ImmuLogic receives funds from NIH to develop cocaine vaccine

May 12, 1997

Nicotine inhaler cleared by FDA

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...